CD8⁺ T cell efficacy enhancement via metabolic immunoengineering involves reprogramming the metabolic pathways of cytotoxic T cells to overcome tumor-induced suppression and boost their anti-cancer activity. This strategy targets the tumor microenvironment (TME), which often imposes metabolic stress that weakens T cell function.